← VIEMED HEALTHCARE, INC.
| Annual Trend | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income | $9.5m |
$8.5m
-10.34%
|
$31.5m
+269.85%
|
$9.1m
-71.06%
|
$6.2m
-31.82%
|
$10.2m
+64.63%
|
$11.4m
+11.38%
|
$15.4m
+34.77%
|
$15.0m
-2.26%
|
|
| Depreciation and amortization | $3.8m | $6.4m | $9.6m | $11.3m | $15.6m | $21.9m | $25.4m | $28.6m | $30.2m | |
| Amortization of deferred financing costs | — | — | — | — | $0 | $0 | $187k | $228k | — | |
| Deferred income tax expense (benefit) | — | $0 | ($8.7m) | $3.9m | $1.7m | ($1.4m) | ($3.8m) | $3.1m | $5.1m | |
| Stock-based compensation expense | $2.7m | $3.9m | $4.9m | $5.2m | $5.2m | $5.8m | $6.3m | $9.1m | $9.0m | |
| Distributions of earnings received from equity method investments | — | — | $0 | $416k | $1.1m | $980k | $147k | $0 | — | |
| Income from equity method investments | — | $110k | ($91k) | ($1.2m) | ($935k) | ($485k) | ($261k) | $0 | — | |
| Investment in equity investments | — | $0 | ($629k) | ($599k) | ($141k) | ($20k) | ($1.0m) | $0 | — | |
| Accounts receivable, net | ($5.3m) | ($12.5m) | ($10.0m) | ($7.3m) | ($12.6m) | ($1.1m) | ($6.1m) | $1.2m | ($3.8m) | |
| Inventory | ($1.3m) | ($306k) | ($2.3m) | ($212k) | $301k | ($472k) | $574k | $59k | ($158k) | |
| Trade payables | $2.5m | $783k | $213k | $133k | ($318k) | ($859k) | $359k | $479k | — | |
| Deferred revenue | $807k | $725k | $94k | $344k | $871k | $851k | $364k | $359k | — | |
| Accrued liabilities | $3.6m | $2.5m | $2.3m | ($4.0m) | $2.5m | $5.0m | $2.9m | $255k | $3.6m | |
| Prepaid expenses and other assets | ($473k) | ($623k) | ($812k) | ($226k) | ($2.8m) | $2.2m | $544k | ($503k) | — | |
| Net cash provided by operating activities | $22.4m |
$19.1m
-14.67%
|
$35.1m
+83.95%
|
$22.5m
-35.93%
|
$27.7m
+23.36%
|
$45.2m
+62.94%
|
$39.1m
-13.54%
|
$51.9m
+32.81%
|
$60.8m
+17.08%
|
|
| Loss (gain) on disposal of property and equipment | $54k | $360k | ($2.3m) | $448k | $346k | $645k | ($1.9m) | ($2.2m) | — | |
| Purchase of property and equipment | ($6.1m) | ($13.4m) | ($13.0m) | ($19.7m) | ($22.9m) | ($26.1m) | ($37.8m) | ($40.0m) | ($31.5m) | |
| Proceeds from sale of property and equipment | $813k | $574k | $5.3m | $596k | $1.1m | $2.6m | $10.3m | $16.2m | — | |
| Equipment and other fixed asset purchases payable at end of period | $6.1m | $13.4m | $13.0m | $19.7m | $739k | $1.4m | $2.2m | $3.2m | — | |
| Equipment sales receivable at end of period | — | — | — | — | $0 | $0 | $2.8m | $0 | — | |
| Cash paid for acquisitions, net of cash acquired | — | — | — | — | $0 | ($28.6m) | ($3.0m) | ($26.3m) | — | |
| Net cash used in investing activities | ($5.3m) | ($12.8m) | ($8.4m) | ($19.7m) | ($24.0m) | ($52.1m) | ($30.7m) | ($50.2m) | ($53.2m) | |
| Loss (income) from debt investment | — | — | — | — | $0 | ($219k) | $1.3m | $0 | — | |
| Proceeds from sale of debt security | — | — | — | — | $0 | $0 | $750k | $0 | — | |
| Payments for debt issuance costs | — | — | — | — | $0 | $0 | ($192k) | ($115k) | — | |
| Non-cash change in debt from the reclassification of debt issuance costs | — | — | — | — | $0 | ($594k) | $0 | $0 | — | |
| Non-cash consideration received for sale of debt security | — | — | — | — | $0 | $0 | $125k | $0 | — | |
| Net cash provided by (used in) financing activities | ($11.8m) |
($3.3m)
+71.63%
|
($9.1m)
-172.02%
|
($5.3m)
+41.33%
|
($15.3m)
-186.90%
|
$2.8m
+118.51%
|
($3.7m)
-230.54%
|
($5.8m)
-56.93%
|
($16.9m)
-191.67%
|
|
| Net increase (decrease) in cash and cash equivalents | $5.3m | $2.9m | $17.6m | ($2.6m) | ($11.5m) | ($4.1m) | $4.7m | ($4.0m) | — | |
| Cash and cash equivalents at beginning of year | $10.4m | $13.4m | $31.0m | $28.4m | $16.9m | $12.8m | $17.5m | $13.5m | $20.0m | |
| Additional Supplementary Disclosures | ||||||||||
| Additional Supplementary Disclosures | ||||||||||
| Income tax payable/receivable | $10k | ($66k) | $254k | ($2.2m) | $1.9m | $2.2m | $1.7m | ($4.1m) | — | |
| Proceeds from exercise of options | $0 | $136k | $1.9m | $112k | $283k | $1.3m | $1.0m | $1.4m | — | |
| Proceeds from term notes | $0 | $4.8m | — | — | $0 | $5.0m | $0 | $9.0m | — | |
| Principal payments on term notes | $0 | $67k | ($142k) | ($152k) | ($4.5m) | ($3.7m) | ($1.1m) | ($730k) | — | |
| Proceeds from revolving credit facilities | — | — | — | — | $0 | $8.0m | $3.0m | $13.0m | — | |
| Principal payments on revolving credit facilities | — | — | — | — | $0 | ($7.0m) | ($5.0m) | ($13.0m) | — | |
| Shares redeemed to pay income tax | — | — | — | ($1.4m) | ($143k) | ($594k) | ($1.1m) | ($1.7m) | — | |
| Shares repurchased under the share repurchase program | ($1.6m) | ($1.5m) | $0 | ($1.4m) | ($9.6m) | $0 | $0 | ($13.2m) | — | |
| Repayments of finance lease liabilities | — | — | — | — | $42k | $157k | $338k | ($50k) | — | |
| Distributions to non-controlling interest | — | — | — | — | $0 | $0 | ($36k) | ($374k) | — | |
| Cash paid during the period for interest | $193k | $333k | $559k | $351k | $231k | $851k | $950k | $874k | — | |
| Cash paid during the period for income taxes, net of refunds | $151k | $338k | $3.3m | $1.8m | ($846k) | $3.6m | $6.8m | $7.4m | — | |
| Net non-cash changes to operating lease | $22.4m | $19.1m | $35.1m | $712k | $530k | ($41k) | $0 | $0 | $60.8m |